Page last updated: 2024-11-07

penicillamine and Dejerine-Roussy Syndrome

penicillamine has been researched along with Dejerine-Roussy Syndrome in 1 studies

Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.

Research Excerpts

ExcerptRelevanceReference
"The generalized dystonia improved in the following 3 months and 3 years respectively in 2 patients."5.30Acute dystonia with thalamic and brainstem lesions after initial penicillamine treatment in Wilson's disease. ( Chu, NS; Huang, CC, 1998)
"The generalized dystonia improved in the following 3 months and 3 years respectively in 2 patients."1.30Acute dystonia with thalamic and brainstem lesions after initial penicillamine treatment in Wilson's disease. ( Chu, NS; Huang, CC, 1998)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, CC1
Chu, NS1

Other Studies

1 other study available for penicillamine and Dejerine-Roussy Syndrome

ArticleYear
Acute dystonia with thalamic and brainstem lesions after initial penicillamine treatment in Wilson's disease.
    European neurology, 1998, Volume: 39, Issue:1

    Topics: Adolescent; Adult; Brain Stem; Dystonia; Female; Hepatolenticular Degeneration; Humans; Magnetic Res

1998